PBI logo

PBI

Pitney Bowes Inc.

$10.37
-$0.16(-1.57%)
71
Overall
80
Value
80
Tech
55
Quality
Market Cap
$1.64B
Volume
945.16K
52W Range
$7.40 - $13.11
Target Price
$13.00

Company Overview

Mkt Cap$1.64BPrice$10.37
Volume945.16KChange-1.57%
P/E Ratio-8.0Open$10.41
Revenue$2.0BPrev Close$10.53
Net Income$-203.6M52W Range$7.40 - $13.11
Div Yield0.36%Target$13.00
Overall71Value80
Quality55Technical80

No chart data available

About Pitney Bowes Inc.

Pitney Bowes Inc., operates as a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to small businesses, large enterprises, and government entities around the world. It operates through SendTech Solutions and Presort Services segments. The SendTech Solutions segment provides physical and digital shipping and mailing technology solutions, and other applications for sending, tracking and receiving of letters, parcels and flats, supplies, and maintenance services, as well as financing alternatives to finance equipment and product purchases. The Presort Services segment offers mail sortation services, which allow clients to qualify volumes of first-class mail, marketing mail, marketing mail flats, and bound printed matter for postal workshare discounts. It markets its products, solutions, and services through direct and inside sales force, global and regional partner channels, direct mailings, and digital channels. The company was formerly known as Pitney Bowes Postage Meter Company. Pitney Bowes Inc. was incorporated in 1920 and is headquartered in Stamford, Connecticut.

Sector: Industrials
Industry: Business Equipment

Latest News

Paradigm Biopharmaceuticals Seeks ASX Quotation for Additional Ordinary Shares

Paradigm Biopharmaceuticals ( ($AU:PAR) ) has provided an update. Paradigm Biopharmaceuticals has applied to the ASX for quotation of 176,880 new o...

TipRanks Australian Auto-Generated Newsdesk13 hours ago

Paradigm Expands Global Phase 3 Knee Osteoarthritis Trial as Peer-Reviewed Data Bolster iPPS Case

TipRanks Australian Auto-Generated Newsdesk5 days ago

Paradigm Biopharmaceuticals Seeks ASX Quotation for Nearly 5 Million New Shares

TipRanks Australian Auto-Generated Newsdesk19 days ago

Paradigm Biopharmaceuticals Flags February 2026 Expiry of 97 Million PAROA Options

TipRanks Australian Auto-Generated Newsdeska month ago
ABCD
1SymbolPriceChangeVol
2PBI$10.37-1.6%945.16K
3
4
5
6

Get Pitney Bowes Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.